Skip to content

For laboratory research use only. Free discreet tracked shipping on orders over $200.

1
CJC-1295 / Ipamorelin Blend 20 mg vial
CJC-1295 / Ipamorelin Blend 20 mg, label detail
Blends

CJC-1295 / Ipamorelin Blend

$110.00

$5.50 per mg

A GHRH analogue and a ghrelin-receptor agonist combined 1:1.

Buy more, save more

Applies to any mix of sizes of this compound. Discount shows in your cart.

  • Batch RP-CIB-2610, lab report sent on request
  • Sealed vial, discreet unbranded packaging
  • Order now and it ships on Monday
Save to wishlist

For in-vitro laboratory research only. Not for human or veterinary use.

Composition

ComponentShare In 20 mg vial
CJC-1295 (no DAC) YaDAIFTQSY+20 50% 10 mg
Ipamorelin AibHNalfKNH₂ 50% 10 mg

Each component comes from a released, independently tested batch. Component batch numbers are listed on the blend’s report.

Specifications

Also known asMod GRF (1-29) 10 mg + Ipamorelin 10 mg
Purity specification≥98.0% per component (HPLC)
FormLyophilized powder, 3 mL glass vial
Storage−20 °C, sealed, protected from light

Batch history

Every batch we have released for this compound, with the report for each. Older reports stay available so you can compare lots.

  1. RP-CIB-2610 Shipping now

    ≥98.0% per component (HPLC)

    Request report

Research overview

Combines modified GRF (1-29), which acts at the GHRH receptor, with ipamorelin, a selective GHS-R1a agonist. The pairing is used to study how the two pituitary signalling pathways interact.

Each component is drawn from a released, batch-tested lot before blending, and the component batch numbers are listed on the blend’s report.

Related products